In The News: Department of Internal Medicine

The FDA requires a new vision-loss warning on popular GLP-1 weight-loss drugs. The warning applies to popular medications like Ozempic, Wegovy, Mounjaro and Zepbound. Health officials say the risk involves a rare eye condition that can lead to permanent vision loss.

The Trump administration acted to ease access to unproven peptide drugs favored by Health Secretary Robert F. Kennedy Jr. and a UNLV doctor is detailing the safety and risks.

An extra hour of sleep is on the way for most Americans and a UNLV doctor is weighing in on how it will affect you and your body.

Philadelphia Eagles quarterback Jalen Hurts is expected to miss the rest of the NFL season after doctors discovered blood clots in his lungs, according to the team.

Pope Leo has begun resuming some work as he recovers from lung cancer surgery, the Vatican said.

A doctor at UNLV is talking about the 'promising but early' results as a study is showing that GLP-1 medications for weight loss and diabetes appear to slow the body’s aging processes.

Pneumonic plague is rare in the United States, but its something that can become serious very quickly. On ARC Las Vegas we talked with our health expert, Dr. Marc J. Kahn, Professor and Chief of Hematology at the Kirk Kerkorian School of Medicine at UNLV.

An upset stomach is common, but persistent digestive symptoms that linger, change or interrupt sleep can signal something more serious, including colon cancer.

A new study suggests sleep quality and consistency may be linked to long-term health. Researchers analyzed wrist-tracker data from more than 95,000 people and found that six to eight hours of sleep was associated with the lowest health risk across many conditions.

A fourth death has been linked to measles in Pennsylvania and a UNLV doctor is sounding the alarm.

Researchers are studying whether a drug designed with artificial intelligence could help people live healthier, longer lives. The experimental drug was originally developed to treat people with idiopathic pulmonary fibrosis, a serious lung disease that causes scarring and breathing problems.

A newly approved pancreatic cancer drug is offering new hope for some patients, but its nearly half-million-dollar price tag is raising questions about who will be able to access it and how families might afford it.